ZSZhigang Shi

Zhigang Shi

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Zhigang Shi has a total of 41 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    A Multi-Stage Surrogate Model for Rapid Reconstruction of Displacement and Stress Fields in Concrete Gravity Dams Super-High Arch Dams

    by Heng Cheng, Wenpeng Bian, Hong Pan, Zhigang Sheng, Yuelei Ruan, Yuntian Zhao, Tao Wan

    Real-time reconstruction of dam-wide displacement and stress fields is critical for hydraulic engineering digital twin systems, yet conventional finite element method (FEM) cannot meet real-time requirements due to its high computational cost. This paper proposes a rapid physical field reconstruction framework based on a multi-stage surrogate model, which takes reservoir water level and air temperature as inputs to build a cascaded mapping pipeline from environmental variables to full dam field reconstruction via representative node responses. We develop a spatial-temporal clustering strategy for representative node selection, and construct three core models: a LightGBM-residual Transformer hybrid model for displacement prediction, a GRU stress predictor with displacement physical constraints, and a dual-encoder model for full-field reconstruction. Validated by a 2D gravity dam FEM model with 10-year monitoring data, the framework achieves R²>0.98 for node displacement prediction, R²>0.99 for stress prediction, and over 0.997 and 0.97 R² for full displacement and stress field reconstruction, with high engineering applicability.

  • Open Access

    Multi-timescale dynamics in descending pain modulation

    by Carl Ashworth, Melissa Martenson, Zhigang Shi, Caitlynn C. De Preter, Mary Heinricher, Flavia Mancini

    Summary: Descending pain-modulatory circuits must coordinate rapid nociceptive responses with slower changes in physiological state, yet how their activity is organized across time remains poorly understood. We investigated this question in physiologically identified pain-modulating neurons of the rostral ventromedial medulla (RVM). The RVM contains ON-and OFF-cells that exert descending control over spinal nociceptive transmission, regulating pain sensitivity and behaviors. By integrating neuronal recordings with probabilistic modeling, we show that unstimulated and stimulus-driven conditions give rise to distinct timescales of ON-and OFF-cell dynamics. During noxious stimulation, we find that population responses undergo rapid activation ( < 1 s) followed by superimposed slow (∼ 100 s) and fast ( < 10 s) recovery dynamics. In the absence of stimulation, the same neurons exhibit slow quasi-periodic fluctuations in firing activity with a characteristic timescale of approximately five minutes. Gaussian-process models show that these slow dynamics are statistically predictable from past activity, indicating structured temporal organization beyond stimulus-evoked responses. Taken together, these results indicate that descending pain-control circuits exhibit structured dynamics encompassing rapid pain-related signaling and slower fluctuations consistent with ongoing physiological state. Significance: Pain regulation requires coordination between rapid defensive responses and slower changes in physiological state, yet how these processes are integrated within descending pain-modulatory circuits remains unclear. We show that neurons in a key brainstem pain-control center, the rostral ventromedial medulla, operate across multiple timescales. Using neuronal recordings and computational modeling, we find that these neurons exhibit both fast responses to painful stimuli and slow, structured fluctuations in ongoing activity. These results demonstrate that descending pain-modulatory neurons exhibit temporal organization beyond immediate reflex-linked responses and provide a quantitative framework for investigating how descending pain modulation is regulated over time.


  • Open Access

    Leptin increases sympathetic nerve activity via induction of its own receptor in the paraventricular nucleus

    by Zhigang Shi, Nicole E Pelletier, Jennifer Wong, Baoxin Li, Andrei D Sdrulla, Christopher J Madden, Daniel L Marks, Virginia L Brooks

    Whether leptin acts in the paraventricular nucleus (PVN) to increase sympathetic nerve activity (SNA) is unclear, since PVN leptin receptors (LepR) are sparse. We show in rats that PVN leptin slowly increases SNA to muscle and brown adipose tissue, because it induces the expression of its own receptor and synergizes with local glutamatergic neurons. PVN LepR are not expressed in astroglia and rarely in microglia; instead, glutamatergic neurons express LepR, some of which project to a key presympathetic hub, the rostral ventrolateral medulla (RVLM). In PVN slices from mice expressing GCaMP6, leptin excites glutamatergic neurons. LepR are expressed mainly in thyrotropin-releasing hormone (TRH) neurons, some of which project to the RVLM. Injections of TRH into the RVLM and dorsomedial hypothalamus increase SNA, highlighting these nuclei as likely targets. We suggest that this neuropathway becomes important in obesity, in which elevated leptin maintains the hypothalamic pituitary thyroid axis, despite leptin resistance.


  • Sites and sources of sympathoexcitation in obese male rats: role of brain insulin

    by Zhigang Shi, Ding Zhao, Priscila A. Cassaglia, Virginia L. Brooks

    In males, obesity increases sympathetic nerve activity (SNA), but the mechanisms are unclear. Here, we investigate insulin, via an action in the arcuate nucleus (ArcN), and downstream neuropathways, including melanocortin receptor 3/4 (MC3/4R) in the hypothalamic paraventricular nucleus (PVN) and dorsal medial hypothalamus (DMH). We studied conscious and α-chloralose-anesthetized Sprague-Dawley rats fed a high-fat diet, which causes obesity prone (OP) rats to accrue excess fat and obesity-resistant (OR) rats to maintain fat content, similar to rats fed a standard control (CON) diet. Nonspecific blockade of the ArcN with muscimol and specific blockade of ArcN insulin receptors (InsR) decreased lumbar SNA (LSNA), heart rate (HR), and mean arterial pressure (MAP) in OP, but not OR or CON, rats, indicating that insulin supports LSNA in obese males. In conscious rats, intracerebroventricular infusion of insulin increased MAP only in OP rats and also improved HR baroreflex function from subnormal to supranormal. The brain sensitization to insulin may elucidate how insulin can drive central SNA pathways when transport of insulin across the blood-brain barrier may be impaired. Blockade of PVN, but not DMH, MC3/4R with SHU9119 decreased LSNA, HR, and, MAP in OP, but not OR or CON, rats. Interestingly, nanoinjection of the MC3/4R agonist melanotan II (MTII) into the PVN increased LSNA only in OP rats, similar to PVN MTII-induced increases in LSNA in CON rats after blockade of sympathoinhibitory neuropeptide Y Y1 receptors. ArcN InsR expression was not increased in OP rats. Collectively, these data indicate that obesity increases SNA, in part via increased InsR signaling and downstream PVN MC3/4R.


  • Faculty Opinions recommendation of A Guide for the Design of Pre-clinical Studies on Sex Differences in Metabolism.

    by Virginia Brooks, Zhigang Shi

    Recently, the National Institutes of Health (NIH) mandated the consideration of sex differences in animal studies, which may be daunting for investigators without appropriate expertise. In a recent Perspective published in Cell Metabolism, Mauvais-Jarvis et al. offer a primer for those who study metabolism in health and disease. Strengths of the article include a detailed rationale for the importance of studying sex differences, several illustrative figures, and excellent examples. Strategies for investigating sex chromosome-linked phenotypes are well-developed. Nevertheless, some metabolism-relevant challenges in experimental design would have benefited from a more in depth discussion, such as the impact of gonadectomy on energy balance and the impairment of female cycling and fertility in animals on a high fat diet {1}. Thus, the age of the animals, the time between gonadectomy and experiments, the timing, route, dose, and extent of gonadal hormone replacement and the necessity of verifying expected manipulations in gonadal hormones (see {2} for an excellent overview) as well as the composition and timing of a high fat diet are additional considerations. For discussions of the impact of sex on various metabolic issues, the reader is referred to several excellent recent reviews by Clegg and colleagues (e.g. {3-7}).


  • Open Access

    Arcuate neuropeptide Y inhibits sympathetic nerve activity via multiple neuropathways

    by Zhigang Shi, Christopher J. Madden, Virginia L. Brooks

    Obesity increases sympathetic nerve activity (SNA) via activation of proopiomelanocortin neurons in the arcuate nucleus (ArcN), and this action requires simultaneous withdrawal of tonic neuropeptide Y (NPY) sympathoinhibition. However, the sites and neurocircuitry by which NPY decreases SNA are unclear. Here, using designer receptors exclusively activated by designer drugs (DREADDs) to selectively activate or inhibit ArcN NPY neurons expressing agouti-related peptide (AgRP) in mice, we have demonstrated that this neuronal population tonically suppresses splanchnic SNA (SSNA), arterial pressure, and heart rate via projections to the paraventricular nucleus (PVN) and dorsomedial hypothalamus (DMH). First, we found that ArcN NPY/AgRP fibers closely appose PVN and DMH presympathetic neurons. Second, nanoinjections of NPY or an NPY receptor Y1 (NPY1R) antagonist into PVN or DMH decreased or increased SSNA, respectively. Third, blockade of DMH NPY1R reversed the sympathoinhibition elicited by selective, DREADD-mediated activation of ArcN NPY/AgRP neurons. Finally, stimulation of ArcN NPY/AgRP terminal fields in the PVN and DMH decreased SSNA. Considering that chronic obesity decreases ArcN NPY content, we propose that the ArcN NPY neuropathway to the PVN and DMH is pivotal in obesity-induced elevations in SNA.


  • Insulin increases sympathetic nerve activity in part by suppression of tonic inhibitory neuropeptide Y inputs into the paraventricular nucleus in female rats

    by Priscila A. Cassaglia, Zhigang Shi, Virginia L. Brooks

    Following binding to receptors in the arcuate nucleus (ArcN), insulin increases sympathetic nerve activity (SNA) and baroreflex control of SNA via a pathway that includes the paraventricular nucleus of the hypothalamus (PVN). Previous studies in males indicate that the sympathoexcitatory response is mediated by α-melanocyte stimulating hormone (α-MSH), which binds to PVN melanocortin type 3/4 receptors (MC3/4R). The present study was conducted in α-chloralose-anesthetized female rats to test the hypothesis that suppression of inhibitory neuropeptide Y (NPY) inputs to the PVN is also involved. In support of this, blockade of PVN NPY Y1 receptors with BIBO 3304 (NPY1x), ArcN insulin nanoinjections, and PVN NPY1x followed by ArcN insulin each increased lumbar SNA (LSNA) and its baroreflex regulation similarly. Moreover, prior PVN injections of NPY blocked the sympathoexcitatory effects of ArcN insulin. Finally, PVN nanoinjections of the MC3/4R inhibitor SHU9119 prevented both the acute (15 min) and longer, more slowly developing (60 min), increases in LSNA in response to ArcN insulin. In conclusion, in females, ArcN insulin increases LSNA, in part, by suppressing tonic PVN NPY inhibition, which unmasks excitatory α-MSH drive of LSNA. Moreover, the steadily increasing rise in LSNA induced by ArcN insulin is also dependent on PVN MC3/4R.


  • Open Access

    PVN Neuropeptide Y Contributes to the Sympathoexcitatory Effect of Leptin

    by Zhigang Shi, Baoxin Li, Virginia Brooks

    Intracerebroventricular (ICV) leptin administration increases sympathetic nerve activity (SNA) via a neuronal pathway that includes the paraventricular nucleus of the hypothalamus (PVN). PVN Neuropeptide Y (NPY) tonically inhibits SNA via type 1 receptors (Y1R). Leptin inhibits NPY neurons; however, whether leptin increases SNA in part by decreasing tonic PVN NPY inhibition is unknown. To test this hypothesis, we determined if blockade of PVN Y1R (Y1Rx) elicits smaller increases in lumbar SNA (LSNA) after ICV leptin (3 μg) in α ‐chloralose anesthetized male SD rats. LSNA was increased 90 min after ICV leptin (to 158±8% of control, n=5; P<0.05), but not after ICV artificial cerebrospinal fluid (aCSF; to 112±2%, n=5). In rats given ICV aCSF, subsequent PVN Y1Rx (bilateral BIBO3304, 60 pmol/60 nL) increased LSNA to 146±5 % of control (P<0.05). However, after ICV leptin, neither PVN Y1Rx (to 171±10 %) nor PVN aCSF (160±18 to 177±19%, n=5) significantly increased LSNA. These data support our hypothesis that leptin reduces tonic PVN NPY inhibition of LSNA. Leptin increases SNA in part via activation of PVN melanocortin 3/4 receptors (MC3/4R), and PVN presympathetic neurons express both Y1R and MC4R. Therefore, to test if leptin‐induced decreases in PVN NPY inhibition unmask MC3/4R excitation, we next determined if the MC3/4R agonist MTII increases LSNA more after Y1Rx. Bilateral PVN MTII (60 pmol/60 nL) did not alter LSNA (110±5% to 112±10 %, n=3); however, after Y1Rx, MTII increased LSNA from 124±3% to 164±6% (P<0.05, n=4). In conclusion, leptin decreases tonic PVN NPY inhibition of SNA, which may contribute to leptin‐induced increases in SNA by exposing enhanced MC3/4R excitatory drive of PVN presympathetic neurons. Supported by NIH HL088552 & AHA.

  • Obesity-induced increases in sympathetic nerve activity: Sex matters

    by Virginia L. Brooks, Zhigang Shi, Seth W. Holwerda, Paul J. Fadel